Related Experiment Video
Updated: Feb 16, 2026
11:32
Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
Published on: February 23, 2014
15.7K
Pneumococcal vaccination and chronic respiratory diseases
Filipe Froes1, Nicolas Roche2, Francesco Blasi3,4
1Chest Department, Hospital Pulido Valente, North Lisbon Hospital Center, Lisbon, Portugal.
International Journal of Chronic Obstructive Pulmonary Disease
|December 20, 2017
Summary
Pneumococcal and influenza vaccines can prevent infections and exacerbations in COPD patients. Early pneumococcal vaccination may help maintain health status, but awareness and coverage remain low.
Area of Science:
- Pulmonology
- Immunology
- Public Health
Background:
- Patients with chronic obstructive pulmonary disease (COPD) and other chronic respiratory diseases are highly susceptible to pulmonary infections.
- These infections are significant contributors to exacerbations, hospitalizations, disease progression, and mortality in COPD patients.
Purpose of the Study:
- To review and discuss the evidence for pneumococcal vaccination efficacy in patients with chronic respiratory diseases, particularly COPD.
- To highlight the role of vaccination in preventing respiratory infections and acute exacerbations.
Main Methods:
- Review of existing evidence on pneumococcal vaccination efficacy.
- Discussion of findings from the Community-Acquired Pneumonia Immunization Trial in Adults (CAPITA).
Main Results:
- The Community-Acquired Pneumonia Immunization Trial in Adults (CAPITA) demonstrated the efficacy of pneumococcal conjugate vaccine in older adults, including those with chronic lung diseases.
- Evidence suggests pneumococcal and influenza vaccinations can prevent community-acquired pneumonia and acute exacerbations in COPD patients.
- Early pneumococcal vaccination may help maintain stable health status in COPD patients.
Conclusions:
- Pneumococcal and influenza vaccinations are effective in preventing pneumonia and exacerbations in COPD patients.
- Despite proven efficacy, pneumococcal vaccine coverage and awareness are suboptimal and require improvement.
- Enhanced communication from respiratory physicians regarding vaccination benefits is crucial for patients with chronic respiratory diseases.
Related Concept Videos
01:30Pneumonia V: Nursing management and Prevention
3.6K
Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
3.6K
01:30Pneumonia III: Complications and Assessment
930
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
930
01:30Pneumonia I: Introduction
939
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
939
01:24Chronic Obstructive Pulmonary Disease
2.6K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
2.6K
01:29Pneumonia II: Pathophysiology
3.2K
The pathophysiology of pneumonia involves the following steps:
3.2K
01:29Chronic Obstructive Pulmonary Disease-V: Management
3.3K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
3.3K